Bergers, G., Javaherian, K., Lo, K. M., Folkman, J. and Hanahan, D (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812.[Abstract/Free Full Text]
Carmeliet, P., Lampugnani, M. G., Moons, L., Breviaro, F., Compernolla, V., Bono, F., Balconi, G., Spagnuolo, R., Oostuyse, B., Dewerchin, M., Zaneti, A., Mattot, V., Nuyens, D., Lutgens, E., Clotman, F., de Ruiter, M. C., Gittenberger-de-Groot, A., Poelmann, R., Lupu, F., Herbert, J. M. and Dejana, E (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial cell survival and angiogenesis. Cell 23, 147-157.
Chao, M. V. and Hempstead, B. L (1995). p75 and trk: a two receptor system. Trends Neurosci 18, 321-326.[Medline]
Darland, D. C. and D'Amore, P. A (1999). Blood vessel maturation: vascular development comes of age. J. Clin. Invest 103, 157-158.[Medline]
Dejana, E., Bazzoni, J. and Lampugnani, M. G (1999). The role of endothelial cell-to-cell junctions in vascular morphogenesis. Thromb. Haemostasis 82, 755-761.[Medline]
Donovan, M. J., Miranda, R., Kraemer, R., McCaffrey, T., Tessorollo, L., Mahadeo, D., Kaplan, D. R., Tsoulfas, P., Parada, L., Toran-Allerand, C., Hajjar, D. and Hempstead, B. L (1995). Neurotrophin and neurotrophin receptors in vascular smooth muscle cells: regulation of expression in response to injury. Am. J. Pathol 147, 309-324.[Abstract]
Donovan, M. J., Hahn, R., Tessarollo, L. and Hempstead, B. L (1996). Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nat. Genet 14, 210-213.[Medline]
Drake, C. J. and Little, C. D (1995). Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic development. Proc. Natl. Acad. Sci.USA 92, 7657-7661.[Abstract/Free Full Text]
Edelberg, J. M., Aird, W. C., Wu, W., Rayburn, H., Mamuya, W. S., Mercola, M. and Rosenberg, R. D (1998). PDGF mediates cardiac microvascular communication. J. Clin. Invest 102, 837-843.[Medline]
Ernfors, P., Lee, K. F. and Jaenisch, R (1994). Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147-150.[Medline]
Fishman, M. C. and Chien, K. R (1997). Fashioning the vertebrate heart: earliest embryonic decisions. Development 124, 2099-2117.[Abstract]
Gerber, H. P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G. A., Ramgell, L., Wright, B. D., Radtko, F., Aguet, M. and Ferrara, N (1999). VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159.[Abstract]
Hendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F.-J., Simmons, M. and Bonow, R. O (2000). Effect of intracoronary recombinant human vascular endothelia growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 101, 118-121.[Abstract/Free Full Text]
Hiltunen, J. O., Arumae, U., Moshnyakov, Saarma, M (1996). Expression of mRNAs for neurotrophins and their receptors in developing rat heart. Circ. Res 79, 930-939.[Abstract/Free Full Text]
Jones, K. R., Farinas, I., Backus, C. and Reichardt, L. F (1994). Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999.[Medline]
Labouyrie, E., Dubus, P., Groppi, A., Mahon, F. X., Ferrer, J., Parrens, M., Reiffers, J., de Mascarel, A. and Merlio, J. P (1999). Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol 154, 405-415.[Abstract/Free Full Text]
Lewin, G. R. and Barde, Y. A (1996). Physiology of the neurotrophins. Ann. Rev. Neurosci 19, 289-317.[Medline]
Lodge, P. A., Haisch, C. E. and Thomas, F. T (1992). A simple method of vascular endothelial cell isolation. Transplant. Proc 24, 2816-2817.[Medline]
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K. and Isner, J. M (1998). Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of ph VEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.[Abstract/Free Full Text]
Mack, C. A., Patel, S. R., Schwarz, E. A., Zanzonico, P., Hahn, R. T., Ilercil, A., Devereux, R. B., Goldsmith, S. J., Christian, T. F., Sanborn, T. A., Kovesdi, I., Hackett, N., Isom, O. W., Crystal, R. G. and Rosengart, T. K (1998). Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thor. Cardiovasc. Surg 115, 168-76.[Abstract/Free Full Text]
Ringstedt, T., Linnarsson, S., Wagner, J., Lendahl, U., Kokaia, A., Arenas, E., Ernfos, P. and Ibanez, C (1998). BDNF regulates reelin expression and Cajal-Retzius cell development on the cerebral cortex. Neuron 21, 299-310.
Risau, W (1997). Mechanisms of angiogenesis. Nature 386, 671-674.[Medline]
Scarisbrick, I. A., Jones, E. G. and Jackson, P. J (1993). Coexpression of the mRNAs for NGF, BDNF and NT-3 in the cardiovascular system of pre and post natal rat. J. Neurosci 13, 875-893.[Abstract]
Schott, J. J., Benson, D. W., Basson, C. T., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E. and Seidman, J. G (1998). Congenital heart disease caused by mutations in the transcription factor NKX 2.5. Science 281, 108-111.[Abstract/Free Full Text]
Schwartz, P. M., Borghesani, P. R., Levy, R. L., Pomeroy, S. L. and Segal, R. A (1997). Abnormal cerebellar development and foliation in the BDNF/ mice reveals a role for neurotrophins in CNS patterning. Neuron 19, 269-281.[Medline]
Snider, W. D (1994). Functions of the neurotrophins during nervous-system development \320 what the knockouts are teaching us. Cell 77, 627-638.[Medline]
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M. and Blau, H. M (1998). VEGF gene therapy to muscle: potential role for vasculogenesis in adults. Mol. Cell 2, 549-558.
Suri, C., Jones, P., Patan, S., Bartunkova, S., Maisonpierre, P., Davis, S., Sato, T. and Yancopoulos, G (1996). Requisite role of angiopoitin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.[Medline]
Timmusk, T., Belluardo, N., Metsis, M. and Persson, H (1993). Widespread and developmentally regulated expression of neurotrophin-4mRNA in rat brain and peripheral tissues. Eur. J. Neurosci 5, 605-613.[Medline]
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Glazer, N., Holash, J., McDonald, D. M. and Yancopoulos, G. D (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med 6, 460-463.[Medline]
Wang, H. U., Chen, Z.-F. and Anderson, D. J (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.[Medline]
Yancopoulos, G. D., Klagsbrun, M. and Folkman, J (1998). Vasculogenesis, angiogenesis and growth factors: Ephrins enter the fray at the border. Cell 93, 661-664.[Medline]
